C4 Therapeutics Inc (CCCC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -20,971 | -66,335 | -44,540 | -22,705 | -11,912 |
| Depreciation Amortization | 735 | 1,931 | 1,489 | 857 | 416 |
| Accounts receivable | 828 | 139 | 482 | -3,923 | 1,303 |
| Accounts payable and accrued liabilities | -1,965 | 467 | -133 | 462 | -2,100 |
| Other Working Capital | -8,863 | -13,177 | -7,369 | -10,289 | -5,584 |
| Other Operating Activity | 5,302 | 9,726 | 4,415 | 4,338 | 1,211 |
| Operating Cash Flow | $-24,934 | $-67,249 | $-45,656 | $-31,260 | $-16,666 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -176,303 | -189,855 | -135,979 | -103,942 | N/A |
| PPE Investments | -421 | -650 | -359 | -75 | -184 |
| Sale Of Investment | 114,994 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $-61,730 | $-190,505 | $-136,338 | $-104,017 | $-184 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 11,973 | 11,973 | 11,973 | N/A |
| Common Stock Issued | 166 | 195,961 | 764 | 232 | 156 |
| Common Stock Repurchased | N/A | -921 | -937 | -851 | N/A |
| Other Financing Activity | -317 | 141,919 | 143,079 | 141,026 | 0 |
| Financing Cash Flow | $-151 | $348,932 | $154,879 | $152,380 | $156 |
| Beginning Cash Position | 184,304 | 93,126 | 93,126 | 93,126 | 93,126 |
| End Cash Position | 97,489 | 184,304 | 66,011 | 110,229 | 76,432 |
| Net Cash Flow | $-86,815 | $91,178 | $-27,115 | $17,103 | $-16,694 |
| Free Cash Flow | |||||
| Operating Cash Flow | -24,934 | -67,249 | -45,656 | -31,260 | -16,666 |
| Capital Expenditure | -421 | -650 | -359 | -75 | -184 |
| Free Cash Flow | -25,355 | -67,899 | -46,015 | -31,335 | -16,850 |